Concepedia

Author

Dirk Holzinger

University Hospital MünsterORCID

Also Known As

Alexander Kai‐Lik So, Anita Dhanrajani, Chiara Passarelli, Claas H. Hinze, D Holzinger, D. Holzinger, Dirk Holzinger, Erbil Unsal, Friedrich Herrmann, G. Ganser

171

Publications

6.5K

Citations

45

H-Index

66

Concepts

All Affiliations

University Hospital MünsterUniversity of Duisburg-EssenUniversity of MünsterUniversity Medical Center UtrechtUniversity College London
DH

About

Dirk Holzinger is an author at University Hospital Münster specializing in medicine, immunology, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

17

1.6K

2

Health Sciences

1

1

420

3

Public Health

1

1

18

4

Biochemistry

1

1

121

5

Cell Biology

1

1

51

Dirk Holzinger

×

64

Publications

5.4K

Citations

41

H-Index

YearCitations

<i>Staphylococcus aureus</i> phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection

Lorena Tuchscherr, Eva Medina, Muzaffar Hussain,

EMBO Molecular Medicine

2011

430

Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils

Bettina Löffler, Muzaffar Hussain, Matthias Grundmeier,

PLoS Pathogens

2010

420

Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

Eric S. Weiss, Charlotte Girard, Dirk Holzinger,

Blood

2018

381

Effectiveness of First‐Line Treatment With Recombinant Interleukin‐1 Receptor Antagonist in Steroid‐Naive Patients With New‐Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study

Sebastiaan J. Vastert, Wilco de Jager, Bo Jan Noordman,

Arthritis & Rheumatology

2013

257

Induction of MxA Gene Expression by Influenza A Virus Requires Type I or Type III Interferon Signaling

Dirk Holzinger, Carl Jorns, Silke Stertz,

Journal of Virology

2007

239

Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

Alessandro Consolaro, Gabriella Giancane, Alessandra Alongi,

The Lancet Child & Adolescent Health

2019

198

Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study

Nienke M. ter Haar, E. H. Pieter van Dijkhuizen, Joost F. Swart,

Arthritis & Rheumatology

2019

182

MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis

Ivy Y. Choi, Daniëlle M. Gerlag, Marieke J Herenius,

Annals of the Rheumatic Diseases

2013

164

<i>Staphylococcus aureus</i> Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome

Dirk Holzinger, Laura Gieldon, Vijayashree Mysore,

Journal of Leukocyte Biology

2012

163

Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

Julian Thalhammer, Gerhard Kindle, Alexandra Nieters,

Journal of Allergy and Clinical Immunology

2021

161

Page 1